News

WBAL-TV17h
COPD in Women: How the condition presents differently in female patients
Dr. Albert J. Polito from Mercy Medical Center joins Jenyne for a conversation about lung conditions such as COPD and asthma and how they present in female patients.
Merck buys Raleigh pharma company for $10 billion, drawn by new COPD drug
Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...
Fierce Pharma3d
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...
Zacks.com on MSN2d
Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?
MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.
The Lancet3d
Transforming COPD management: the role of dupilumab
Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...
Fierce Pharma4d
Respiratory pharma royalty rally around rural COPD education and support drive
Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...
Healio12d
Q&A: Mepolizumab marks second biologic approved for COPD with eosinophilic phenotype
The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
MedPage Today on MSN4d
Switch to Dry-Powder Inhaler Worsened COPD, Asthma Patient Outcomes
Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...
The American Journal of Managed Care3d
Itepekimab Shows Mixed Results in Phase 3 COPD Trials
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Merck Acquires Verona Pharma for $10B to Support Portfolio with COPD Drug Ohtuvayre Ahead of Keytruda Patent Expiration
Merck & Co. Inc. (NYSE:MRK) is one of the most undervalued NYSE stocks to buy now. On July 9, Merck announced its acquisition ...
News Medical on MSN4d
Vaping linked to higher COPD risk, meta-analysis finds
A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds ...